May 4, 2007
Copaxone, Antibiotic Combination Could Help MS Sufferers
Teva Pharmaceuticals said a combination of Copaxone and antibiotic minocycline reduced brain lesions in patients with relapsing-remitting multiple sclerosis, compared to receiving Copaxone alone.
New data from a randomized, double-blind study showed that a combination of Copaxone with the oral antibiotic minocycline reduced T1 Gadolinium enhancing lesions of the brain by 63% and reduced the number of new T2 lesions in patients by 65%. These results trended toward but did not reach statistical significance.